# Defiant Health > Medically supervised wellness, weight loss, peptide therapy, IV therapy, aesthetics, and recovery services in Lisle, IL — serving Naperville, Downers Grove, Wheaton, Bolingbrook, Lombard, and the western Chicago suburbs. Defiant Health is a longevity and performance medicine clinic at 5100 Lincoln Ave, Lisle, IL. Every protocol starts with bloodwork (samples collected at home with a Tasso device, results reviewed in-clinic), a 3D body composition scan, and a provider consult. We don't take insurance, we don't sell hype, and we publish hedged, research-honest claims about every protocol we run. ## Core service pages - [Weight Loss](https://defianthealth.io/weight-loss/): Medical weight loss with GLP-1 protocols. Bi-weekly titration, body composition tracking, and integration with peptide and training plans. - [Tirzepatide](https://defianthealth.io/tirzepatide/): GIP/GLP-1 dual-agonist for weight loss; SURMOUNT-1 averaged 22.5% body weight loss at the highest dose. - [Semaglutide](https://defianthealth.io/semaglutide/): GLP-1 receptor agonist; STEP-1 averaged 14.9% body weight loss. - [Virtual Consults](https://defianthealth.io/virtual-consults/): $50 virtual hormone and metabolic optimization consults for Illinois residents outside the Lisle area. Video visit with a provider, personalized plan; the consult fee is separate from program costs and not credited toward a program. If labs would help, Defiant recommends an at-home test the client orders themselves. - [Peptide Therapy](https://defianthealth.io/peptide-therapy/): Peptide menu including BPC-157, TB-500, GHK-Cu, sermorelin, enclomiphene, and MOTS-c. - [Sermorelin](https://defianthealth.io/sermorelin/): GHRH analog that asks the pituitary to release the body's own growth hormone in natural overnight pulses. - [BPC-157](https://defianthealth.io/bpc-157/): Synthetic 15 amino acid peptide derived from human gastric juice protein. Studied primarily in animal models for tissue repair across muscle, tendon, ligament, gut, and bone. Not FDA approved; under PCAC review July 23-24, 2026 for the 503A bulks list. - [IV Therapy & Vitamin Shots](https://defianthealth.io/iv-shots/): IV drips, NAD+ injections, B12, glutathione, Niagen, and other vitamin shots. - [Wellness Hub](https://defianthealth.io/wellness/): Recovery and longevity services including HBOT, infrared sauna, cryotherapy, BrainTap, Styku 3D body scan, personal training, and massage. - [Hyperbaric Oxygen Therapy (HBOT)](https://defianthealth.io/hyperbaric-oxygen-therapy/): OxyHealth 64D hard-shell multiplace chamber (seats 2), up to 2.0 ATA, for tissue healing, recovery, cognitive function, and longevity. - [Infrared/Dry Heat Sauna](https://defianthealth.io/infrared-sauna/): Radia IR 300 hybrid cabin that runs as infrared OR traditional sauna. - [Cryotherapy](https://defianthealth.io/cryotherapy/): Whole-body cold therapy in an Everest CryoBuilt chamber, 3:30 max session. - [Contrast Therapy](https://defianthealth.io/contrast-therapy/): Alternating infrared sauna heat and whole-body cryotherapy in one guided session for recovery and circulation. Pairs the Radia IR 300 sauna with the Everest CryoBuilt cryo chamber. - [Styku 3D Body Scan](https://defianthealth.io/styku/): Non-invasive 3D body composition baseline and progress tracking. - [BrainTap Meditation](https://defianthealth.io/braintap/): Guided meditation with light and sound therapy. - [Personal Training](https://defianthealth.io/personal-training/): 1-on-1 in-clinic, virtual, and GLP-1 muscle-preservation coaching. - [Diagnostic Testing](https://defianthealth.io/diagnostic-testing/): Food sensitivity panels, allergy testing, combo panels. Defiant writes the order and you collect your sample at home with a Tasso device, no lab visit needed. - [Aesthetics](https://defianthealth.io/aesthetics/): Neurotoxin, dermal filler, chemical peels, microneedling, and other aesthetic services. - [Botox, Dysport & Xeomin](https://defianthealth.io/botox/): Wrinkle-relaxing neurotoxin injections (Botox, Dysport, Xeomin) by trained injectors in Lisle, IL at $11/unit. Softens forehead lines, frown lines, and crow's feet. - [Dermal Fillers & Biostimulators](https://defianthealth.io/dermal-fillers/): HA dermal fillers (Juvederm, Restylane) and collagen-stimulating biostimulators (Sculptra, Radiesse) in Lisle, IL, placed by trained injectors. Restore volume in cheeks, lips, and jawline, soften folds and smile lines, and improve contour. HA fillers add volume immediately and are reversible; biostimulators (Sculptra, Radiesse) build collagen gradually and can last up to two years. From $600. Serving Naperville and the western suburbs. - [Acne Bootcamp](https://defianthealth.io/acne-bootcamp/): Multi-phase clinical acne program with clinical skin analysis, medical-grade and prescription protocols, and skin barrier repair over a 6 to 12 week plan. Acne consultation $100. - [Microneedling](https://defianthealth.io/microneedling/): Collagen induction therapy in Lisle, IL for acne scars, texture, fine lines, and pores, with optional exosome and PDGF boosters. From $350. - [Medical-Grade Facials](https://defianthealth.io/facials/): Clinical facials in Lisle, IL from $100, including Signature, Hydra Dermabrasion, Dermaplane, Ageless, Custom, and Mini. Professional extractions and active treatments customized to your skin. - [Laser Hair Removal](https://defianthealth.io/laser-hair-removal/): Laser hair reduction in Lisle, IL from $99 by treatment area (small, medium, large, full body) with package pricing. Long-term reduction for the face, underarms, bikini, legs, arms, and back. - [Membership](https://defianthealth.io/membership/): Three tiers (Essential $50, Premier $150, Elite $250) with discounts and monthly service credits. ## Blog (educational, research-honest) - [GLP-1 Diarrhea: Why It Happens and What Helps](https://defianthealth.io/blog/glp-1-diarrhea/): Diarrhea is one of the most common GLP-1 side effects: in the weight-loss trials 30% on semaglutide 2.4 mg (vs 16% placebo) and 19/21/23% on tirzepatide 5/10/15 mg (vs 8% placebo, pooled label); it clusters around dose escalation and eases over time, and few stop treatment over it (diarrhea discontinuation 0.7% vs 0.1% on semaglutide; GI-group discontinuation 1.9-4.3% vs 0.5% on tirzepatide). Mechanism: GLP-1 receptors in the gut + slowed gastric emptying change gut rhythm (same drug can cause constipation in one person, diarrhea in another, even both in a month); diet contributes (greasy meals, sugar alcohols like sorbitol/xylitol/maltitol, whey/dairy shakes, sudden fiber). What may help (clinical practice, not trial-tested): smaller lower-fat meals, cut sugar alcohols, check the shake, steady fluids + electrolytes, add soluble fiber slowly, log symptoms vs injection day; loperamide only with prescriber okay; do NOT self-adjust your dose. KEY RISK is dehydration -> acute kidney injury (both labels carry a volume-depletion AKI warning); call the provider same-day for diarrhea lasting days, bloody/black stools, dizziness/faintness, very little/dark urine, severe abdominal pain radiating to the back (pancreatitis), or fever. Defiant's GLP-1 program (Lisle IL, from $295/mo) uses bi-weekly titration check-ins + nurse access to catch GI issues early. Cites the semaglutide and tirzepatide prescribing information and Lilly SURMOUNT-1 GI data. - [Does Cryotherapy Help You Lose Weight?](https://defianthealth.io/blog/does-cryotherapy-help-you-lose-weight/): No, not in any way you'd notice on the scale, and the viral "burns 800 calories in three minutes" claim has NO study behind it. Best evidence (Karppinen 2025, Obesity; n=19 adults with obesity, 28 WBC sessions at -110C over a 12-month lifestyle program) found NO significant extra weight loss (9.9% vs 8.0% at 12 mo), NO brown-fat activation, and no change in most metabolic responses; a small 5-month glucose (-0.41 mmol/L) and LDL (-0.44 mmol/L) signal needs a bigger trial. A 20-session menopausal-women study (Wiecek 2020, J Clin Med; n=37 at -130C) saw a ~2 cm waist drop and ~0.5 kg fat, but had NO untreated control. A 2022 scoping review (Fontana, J Therm Biol; 8 eligible studies of 856) concluded the data fail to reach definitive conclusions. Cold physiology is real (shivering + brown fat burn energy) but a 3-minute chamber is the wrong dose; day-to-day scale changes are mostly water (track fat vs fluid with a Styku scan). Cryotherapy MAY support post-training recovery and alertness, not weight loss. Defiant's Everest CryoBuilt chamber in Lisle IL: $50 single, $299 unlimited monthly, $25 first session, included as a Core Wellness credit in every membership; serves Naperville/Downers Grove/Wheaton/Oak Brook. Cites Karppinen 2025, Wiecek 2020, and Fontana 2022. - [Hormonal Acne in Women: Signs and What Helps](https://defianthealth.io/blog/hormonal-acne-in-women/): 'Hormonal acne' is an informal label (not a diagnosis) for hormone-influenced acne, usually in adult women. Location is a weak clue: in a 374-woman study (Rocha 2018) only 11.2% had jawline-only lesions and 89.8% were multi-region. Better clues are timing and persistence: a premenstrual flare (44% of 400 women, Stoll 2001; higher over age 33, unaffected by severity or oral-contraceptive use), onset/return after age 25, and family history (~50%). Most adult women with acne are normoandrogenic, so routine hormone testing isn't needed unless there are hyperandrogenism signs (irregular periods, hirsutism, scalp hair thinning); PCOS is the most common identified cause (hirsutism in 65-73%); draw androgens in the early follicular phase (days 1-5), morning. Treatment (2024 AAD guideline, Reynolds): STRONG for benzoyl peroxide, topical retinoids, topical antibiotics, oral doxycycline; CONDITIONAL for combined oral contraceptives and spironolactone. SAFA trial (Santer 2023, BMJ; n=410 women, mean age 29.2, topicals allowed): investigator-rated success 19% vs 6% placebo at 12 wk, self-reported improvement 82% vs 63% at 24 wk, symptom-scale gap 1.27 (wk12)->3.45 (wk24), headache 20% vs 12%, no serious AEs, so give it 3+ cycles. Oral prescriptions (spironolactone, birth control) come from the patient's PCP/gynecologist/dermatologist; Defiant doesn't prescribe oral acne meds. Defiant's Acne Bootcamp (Lisle IL) is a 6-12 wk program: clinical skin analysis, in-clinic treatments, barrier repair, home regimen, prescription protocols where appropriate; results vary and aren't guaranteed. Cites Rocha 2018, Stoll 2001, the AAD 2024 guideline, and SAFA 2023. - [Why You Should Run Bloodwork Before Starting a GLP-1](https://defianthealth.io/blog/bloodwork-before-glp-1/): Bloodwork should come before your first GLP-1 dose. A baseline panel tells the provider whether semaglutide or tirzepatide is appropriate, informs the starting dose, and catches conditions that have been working against your weight (e.g., hypothyroidism). Typical pre-GLP-1 workup: A1C + fasting glucose (normal / prediabetic A1C 5.7-6.4% / diabetic 6.5%+, per ADA), comprehensive metabolic panel (kidney + liver + electrolytes), lipid panel, TSH, CBC; fasting insulin if insulin resistance is suspected. Intake also screens FDA-label contraindications: personal/family history of medullary thyroid carcinoma or MEN 2, and caution with prior pancreatitis; GLP-1s aren't used in pregnancy. Baselines also let you watch A1C/lipids/metabolic markers improve (GLP-1s showed 14.9% weight loss in STEP 1 and 20.9% at the top tirzepatide dose in SURMOUNT-1). Defiant (Lisle IL) builds lab review into every GLP-1 program but does NOT draw blood in-clinic: the provider writes the order, you draw at your PCP or via Rythm Health (referral link saves $20), and results are reviewed before the protocol starts. $50 consultation (not credited), programs from $295/mo with bi-weekly titration, monthly Styku scans, weekly nurse check-ins. Cites STEP 1 (Wilding 2021), SURMOUNT-1 (Jastreboff 2022), the ADA Standards of Care, and the FDA semaglutide label. SEO-only, no ads. - [IV Hydration vs Drinking Water: What Research Shows](https://defianthealth.io/blog/iv-hydration-vs-drinking-water/): For most healthy people drinking rehydrates about as well as an IV; 'faster' is not the same as 'better.' An IV raises blood volume within minutes, but in a randomized crossover of 8 trained cyclists (Casa 2000, Med Sci Sports Exerc; rehydrated to 50% of a 4% body-mass loss with 0.45% saline) time to exhaustion in the heat was 29.5 min (IV) vs 34.9 (drink), P=0.07, both far above 18.9 (no fluid); the IV restored plasma volume faster but the DRINK group had lower rectal temp and lactate. Not every drink is equal: in Maughan 2016 (AJCN; 72 euhydrated men, 4-h urine) oral rehydration solution, full-fat and skim milk were retained better than still water (1,337 g), while coffee, tea, cola, juice, sparkling water, and a sports drink did not differ (coffee is not the dehydrator it's made out to be). Sports bodies are skeptical of routine IVs: WADA prohibits IV infusions >100 mL per 12 h outside hospital care/TUE (M2), and USADA says IV for mild dehydration is not well supported. An IV makes sense when you can't keep fluids down (nausea/vomiting), feel faint, or want fluids + vitamins for convenience, not as something a bottle of electrolyte drink can't match in a mildly dehydrated healthy person. No hangover/immunity/detox claims. Defiant (Lisle IL): IV drips $185 each, vitamin shots $50 each, Elite members 20% off, walk-ins welcome. Cites Casa 2000, the NATA fluid-replacement position statement (Casa 2000), WADA/USADA M2, and Maughan 2016. - [GLP-1 Acid Reflux: Why It Happens and What May Help](https://defianthealth.io/blog/glp-1-acid-reflux/): Yes, acid reflux/heartburn show up more on a GLP-1, usually mild. Mechanism: slowed gastric emptying lets stomach contents wash back up. Label rates (weight-loss trials): GERD 5% vs 3% placebo (semaglutide 2.4 mg) and 4/4/5% vs 2% (tirzepatide 5/10/15 mg); dyspepsia 9% vs 3% and 9/9/10% vs 4%; eructation/burping 7% vs <1% and 4/5/5% vs 1%; abdominal pain 20% vs 10% and 9/9/10% vs 5%. The two drugs' trials can't be compared head-to-head. A 2025 Annals of Internal Medicine cohort (Noh 2025; 24,708 GLP-1 vs 89,096 SGLT-2 users with T2D, prior reflux excluded, median 3 yr) found new-GERD RR 1.27 (CI 1.14-1.42, ~0.7 extra/100 over 3 yr) and complications (erosive esophagitis/stricture/Barrett) RR 1.55 (CI 1.12-2.29, ~0.8/1,000). What helps: smaller/slower meals, avoid fatty/late meals + alcohol/carbonation, 2-3 h before lying down, raise the bed head, log symptoms vs dose changes, ask provider/pharmacist before OTC acid reducers; do NOT self-adjust your dose. Red flags (prompt call): dysphagia, repeated vomiting, severe/radiating upper-abdominal pain, black/bloody stools, daily/nighttime heartburn; chest pain is a 911 emergency. Surgery/anesthesia: GLP-1 labels warn of rare pulmonary aspiration; a 2024 five-society guidance (incl. ASA, AGA) says most continue but higher-risk patients (early escalation, active GI symptoms) may need a 24-h liquid diet or retiming, so tell your surgical/anesthesia teams. Defiant's medical weight loss program in Lisle IL ($295/mo, bi-weekly check-ins) catches it early. Cites the semaglutide 2.4 mg and tirzepatide prescribing information, Noh 2025 (Ann Intern Med), and the 2024 ASA multisociety guidance. - [Does Sauna Help You Lose Weight?](https://defianthealth.io/blog/does-sauna-help-you-lose-weight/): A sauna drops the scale by ~0.5 kg per visit, but research shows it is almost entirely WATER (sweat), not fat, and it returns on rehydration. Direct studies: Boraczynski 2018 (230 men, two 10-min at 95C) mean body-mass loss 0.49 kg (0.61%), range 0.2-1.1 kg, HR 79->136 bpm; Podstawski 2019 (45 overweight sedentary men) 0.65 kg over a 60-min treatment, with 'deleterious cardiovascular adaptations' most prevalent in the largest/most obese; Toro 2021 (12 sauna vs 11 control, 12 sessions/4 wk at 100C) NO change in weight or fat tissue; Podstawski 2022 attributes body-mass loss to sweat and notes lower BP after sessions. Larger bodies lose more fluid AND carry more heat strain, so more sweat is not a better session. No verifiable calorie figure (the post declines to invent one). Defiant does NOT market sauna as a fat-loss tool; it may support recovery, relaxation, and sleep. For weight, the evidence-backed levers are food, strength training, sleep, and medical care; track fat-vs-fluid with a Styku scan, not the bathroom scale. Defiant's hybrid infrared/dry-heat cabin in Lisle IL: $45/$65/$85 for 30/45/60 min, first session $25 (30 min)/$40 (45 min), included in membership credits. Cites Boraczynski 2018, Podstawski 2019, Toro 2021, Podstawski 2022. - [GLP-1 Constipation: Why It Happens and What Helps](https://defianthealth.io/blog/glp-1-constipation/): Constipation is a common GLP-1 side effect. In the semaglutide 2.4 mg weight-management trials it hit 24% vs 11% placebo; in SURMOUNT-1 tirzepatide 12-17% (17/17/12% at 5/10/15 mg) vs 6%. A 2024 JAMA review put the range at 11-24%. Mechanism: these drugs delay gastric emptying and slow gut motility, plus eating and drinking less reduces stool bulk. Clinician guidance (AFP 2026) is lifestyle first (scheduled hydration, daily walking, gradual fiber from food), then PEG 3350 as first-line medication, senna/bisacodyl second; an ACG gastroenterologist treats with an osmotic laxative without lowering the GLP-1 dose. Do NOT self-adjust your dose. Red flags for a same-day call: severe belly pain, repeated vomiting, a swollen/hard abdomen or no gas, blood in stool, or no bowel movement for days (the semaglutide label lists postmarketing ileus, intestinal obstruction, and severe constipation including fecal impaction). Defiant's GLP-1 programs ($295/mo, Lisle IL) include weekly nurse check-ins and bi-weekly titration so it gets raised early. Cites the semaglutide label, Lilly SURMOUNT-1 data, AFP 2026, JAMA 2024 (Gudzune), and ACG. - [Can a GLP-1 Help Fatty Liver (MASH)?](https://defianthealth.io/blog/glp-1-for-fatty-liver/): Research suggests yes, with stronger evidence than most GLP-1 'bonus' claims. In Aug 2025 the FDA gave branded semaglutide 2.4 mg accelerated approval for MASH with moderate-to-advanced fibrosis (F2-F3, noncirrhotic), used with diet and exercise, NOT for simple fatty liver, cirrhosis, or compounded versions. ESSENCE (Sanyal 2025, NEJM; first 800 of the phase 3): steatohepatitis resolved without worse fibrosis in 62.9% vs 34.3% placebo, fibrosis improved 36.8% vs 22.4%, at 72 weeks; Part 2 outcomes (cirrhosis/transplant/death) not due until 2029. SYNERGY-NASH (Loomba 2024, NEJM; phase 2, n=190): tirzepatide resolved MASH in 44/56/62% at 5/10/15 mg vs 10%, with weight loss -10.7/-13.3/-15.6% vs -0.8%; tirzepatide is NOT FDA-approved for MASH. Much of the benefit tracks weight loss: in Vilar-Gomez 2015 (n=293 lifestyle), >=10% weight loss resolved NASH in 90% and regressed fibrosis in 45%. About 31.9% of US adults have MASLD (Kim 2025, renamed from NAFLD/NASH in 2023). Diagnosing/staging MASH needs a hepatologist (FibroScan or biopsy); Defiant runs weight management only in Lisle IL ($295/mo, $50 consult) and does not diagnose or treat liver disease. Cites Kim 2025, Sanyal 2025 (ESSENCE), the FDA approval, Loomba 2024 (SYNERGY-NASH), Vilar-Gomez 2015, and AASLD. - [GLP-1s and Prediabetes: What the Research Shows](https://defianthealth.io/blog/glp-1-for-prediabetes/): In the trials most people with prediabetes on a GLP-1 returned to normal blood sugar and far fewer developed type 2 diabetes, but NO GLP-1 is FDA-approved for prediabetes (approved for chronic weight management and type 2 diabetes only). STEP 10 (McGowan 2024, Lancet Diab Endo; n=207, obesity+prediabetes): 81% normoglycemia on semaglutide 2.4 mg vs 14% at 52 wk, weight -13.9% vs -2.7%; nobody who lost >=5% progressed to diabetes. SURMOUNT-1 3-yr (Jastreboff 2025, NEJM; 1,032 with prediabetes): type 2 diabetes in 1.3% vs 13.3% over 176 wk (HR 0.07), 15 mg weight -19.7%; a ~94% risk reduction, NNT ~9 (Lilly). Benefit erodes off treatment: STEP 10 normoglycemia fell 81%->44% by 28 wk off with ~6% regain; SURMOUNT-1 diabetes 1.3%->2.4% after 17 wk off. About half the SURMOUNT-1 effect was mediated by weight loss. Lifestyle still works: DPP (Knowler 2002) cut diabetes 58% (beating metformin's 31%) with 7% weight loss + 150 min/wk. CDC: 115.2M US adults have prediabetes, 8 in 10 unaware. Defiant handles it inside medical weight loss in Lisle IL ($295/mo), labs ordered (drawn at PCP/Rythm), Styku scans, bi-weekly titration. Cites McGowan 2024 (STEP 10), Jastreboff 2025 (SURMOUNT-1), Lilly, Perreault 2022, Knowler 2002 (DPP), CDC, and Wilding 2021 (STEP 1). - [Do Glutathione Shots Work?](https://defianthealth.io/blog/do-glutathione-shots-work/): Maybe, but the evidence is thinner than the marketing. Glutathione is an endogenous tripeptide antioxidant (glutamate/cysteine/glycine); the body makes its own, cysteine is the limiting substrate. ORAL evidence: a 6-month RCT of 54 non-smoking adults (Richie 2015, Eur J Nutr) found 1,000 mg/day raised glutathione 30-35% in erythrocytes/plasma/lymphocytes and 260% in buccal cells, 250 mg/day raised it 17% in blood / 29% in erythrocytes, NK cytotoxicity >2x vs placebo at 3 months, all reversible after a 1-month washout. This overturned the old 1992 single-dose finding (Witschi, ~3 g in 7 people, no plasma rise over 4.5 h) because of daily dosing over months and intracellular measurement. But raising a lab number is not the same as feeling better: the trial showed no energy/skin/illness outcomes. SHOTS/IVs: injecting skips digestion, but a 2018 dermatology review (Sonthalia, Dermatol Pract Concept) found limited clinical support for skin lightening and identified just ONE IV study, with a dubious design and flawed analysis; oral/sublightening results were 'appreciable but reversible.' No large placebo-controlled trials exist for the energy/detox/skin claims. Defiant does NOT offer glutathione for skin lightening and makes no detox claim. Who might still try one: fine as an optional wellness add-on, but expect no specific outcome; cover protein/sleep/alcohol first (they feed endogenous production). At Defiant in Lisle, IL the Glutathione Antioxidant+ shot is $50 on the vitamin-shot menu, members can apply monthly credits; walk-ins welcome; serves Naperville, Downers Grove, Wheaton. Cites Witschi 1992, Richie 2015, and Sonthalia 2018. - [Does Diet Affect Acne? What the Research Says](https://defianthealth.io/blog/does-diet-affect-acne/): Research suggests diet can influence acne, mainly through high-glycemic foods and cow's milk, though less than popular belief and not via the classic suspects (greasy food, chocolate). In a 12-week RCT of 43 young men (Smith 2007, Am J Clin Nutr), a low-glycemic-load diet cut total lesion counts by 23.5 vs 12.0 on a standard diet; a Korean RCT of 32 people (Kwon 2012, Acta Derm Venereol) found fewer inflammatory and non-inflammatory lesions plus smaller oil glands on biopsy. Both are small, and the low-glycemic groups still had acne at the end, so diet reduces lesions rather than clearing skin. The mechanism is insulin/IGF-1 driving sebum; that's why glycemic data is taken more seriously than the greasy-food myth. For dairy, a 2018 meta-analysis of 78,529 people aged 7-30 (Juhl 2018, Nutrients) linked any milk to 28% higher odds of acne (skim 32%, full-fat 22%); yogurt and cheese show a less consistent link, and all dairy data is observational. Adult data: a French cohort of 24,452 adults (Penso 2020, JAMA Dermatol) tied current acne to fatty/sugary products (54%), sugary drinks (18%), and milk (12%). Chocolate evidence is weak/insufficient (Reynolds 2024 AAD guideline). The AAD says more research is needed and that clear skin takes acne-friendly skin care and often medication. To self-test: change one food at a time, wait 6-8 weeks, keep a weekly photo log, and don't spiral into restriction. Defiant runs Acne Bootcamp in Lisle, IL: a 6- to 12-week provider-guided program starting with a clinical skin analysis, combining in-clinic treatments, a home routine, prescription protocols where appropriate, and barrier repair, with diet as one input. Serves Naperville, Downers Grove, Wheaton, Chicago's western suburbs. Cites Smith 2007, Juhl 2018, the AAD diet page, Kwon 2012, Penso 2020, and Reynolds 2024. - [Do GLP-1s Lower Blood Pressure?](https://defianthealth.io/blog/glp-1-and-blood-pressure/): For most people, yes, by a modest amount, and mostly because of the weight loss. In STEP 1 (Wilding 2021, n=1,961) systolic fell about 5 mmHg more than placebo (6.16 vs 1.06); a pooled individual-patient analysis of three STEP trials (Kennedy 2024, Eur Heart J; 3,136 people) found a 4.95 mmHg placebo-adjusted drop that held whether or not people had hypertension (4.78) or started above 130 (4.93). Tirzepatide measured by 24-hour ambulatory monitoring (SURMOUNT-1 ABPM substudy, de Lemos 2024, Hypertension; n=600) lowered 24-h systolic by 7.4 / 10.6 / 8.0 mmHg at 5 / 10 / 15 mg. Most of the effect is the weight: adjusting for weight change shrank the semaglutide effect to ~1 mmHg (nonsignificant), and weight explained ~70% of the tirzepatide effect (consistent with ~1 mmHg per kg lost, Neter 2003). Why a 5-point drop matters: across 48 trials / 344,716 people, each 5 mmHg systolic reduction cut major cardiovascular events ~10% (BPLTTC 2021, Lancet), though that's from BP DRUGS and can't be transferred to a GLP-1. The office-reading average likely understates the real effect because physicians de-escalated BP meds more often on semaglutide (10.9% vs 5.2%; 26.9% vs 3% in resistant hypertension; Kennedy 2024). GLP-1s are NOT FDA-approved to treat hypertension, and no one should change a BP medication on their own (beta-blockers in particular shouldn't be stopped abruptly). The low side: lower BP + eating less + dehydration + a medication dosed for a heavier you can cause lightheadedness worth reporting. Resting heart rate rises a little (tirzepatide +2.1/+2.3/+5.4 bpm; semaglutide label notes a mean 1-4 bpm). About 47.7% of US adults have hypertension and only ~1 in 5 are controlled below 130/80 (NCHS 2024). Defiant runs Custom GLP-1 Protocols in Lisle, IL from $295/mo with a $50 consult, bi-weekly titration, nurse check-ins, and monthly Styku scans; bring home BP readings to your consult. Cites Wilding 2021, Kennedy 2024, de Lemos 2024, Neter 2003, BPLTTC 2021, NCHS 2024, and the FDA semaglutide label. - [Are GLP-1s Bad for Your Kidneys?](https://defianthealth.io/blog/glp-1s-and-kidney-health/): The research points the other way: GLP-1s slowed kidney disease progression in the major trials, and semaglutide now carries an FDA indication (Jan 2025) to slow kidney decline in adults with type 2 diabetes AND chronic kidney disease (diabetes doses). FLOW (Perkovic 2024, NEJM; 3,533 adults with T2D + CKD, mean eGFR 47, median 3.4 y) cut major kidney events 24% (18.7% vs 23.2%) and was stopped early; all-cause death 12.8% vs 15.8%. A meta-analysis of 11 trials / 85,373 (Badve 2025, Lancet Diab Endo) found an 18% reduction in kidney events and 16% in kidney failure, holding at 19% when SELECT (no diabetes, but all had CVD) was folded in. SURPASS-CVOT (Zoungas 2026; tirzepatide vs dulaglutide, 13,165) found 6.0% vs 7.6% (23% reduction). All of this is in people with diabetes and/or existing CKD at diabetes doses, so it does NOT automatically mean a kidney benefit for a healthy-kidney weight-management patient. The real documented risk is acute kidney injury from DEHYDRATION, not the drug acting on kidney tissue: both the semaglutide and tirzepatide labels carry an 'Acute Kidney Injury Due to Volume Depletion' warning (nausea/vomiting/diarrhea), with low trial rates (0.4 vs 0.2 per 100 patient-years for semaglutide 2.4 mg; 0.5% vs 0.2% for tirzepatide) and higher risk during dose escalation and in people with prior renal impairment. eGFR can also mislead after weight loss: it's calculated from creatinine, a muscle breakdown product, so losing muscle lowers creatinine and inflates estimated kidney function (KDIGO 2024 recommends creatinine + cystatin C). Higher-stakes situations on a bad GI week: diuretics/ACE/ARB, regular NSAIDs, kidney stones or a single kidney, heavy training in heat, age over 65. Watch for: >24 h vomiting/diarrhea, much less urine, dark urine, swelling, confusion/lightheadedness. Never self-adjust a dose. Defiant runs kidney markers on the baseline panel for every weight-loss protocol in Lisle, IL (orders written, draw at PCP or Rythm), with bi-weekly titration check-ins, monthly Styku scans, and nurse access, from $295/mo. Cites Perkovic 2024 (FLOW), Badve 2025, the FDA semaglutide and tirzepatide labels, Zoungas 2026 (SURPASS-CVOT), and KDIGO 2024. - [DEXA vs 3D Body Scan vs InBody: Which Is Accurate?](https://defianthealth.io/blog/dexa-vs-3d-body-scan-vs-inbody/): An honest comparison of the three body-composition methods you can book locally. None give a true body fat percentage; each estimates fat from something else and errs in a predictable direction, so for tracking, repeatability beats absolute accuracy. DEXA is the clinical reference and strongest single snapshot, but a July 2026 study scanned 99 adults on three DEXA systems (Hologic Horizon A, Hologic Discovery A, GE Lunar iDXA) the same day and got 36.4% / 34.4% / 35.2% average body fat, significantly different (Ramirez 2026, Int J Obes), so even the reference carries machine-dependent spread. 3D optical scanners (Styku S100) photograph body shape: in 188 adults fat-free mass was within 1.2 kg of DEXA (concordance 0.97) with excellent repeatability (repeat scans differed 0.41 kg fat mass, 0.60% BF; Bennett 2022, Clin Nutr), though individual readings can sit several kg off. Against a tougher 4-component reference, 3 of 4 commercial scanners met a 5% equivalence test and Styku did not, while all four were reliable on repeat scans (Tinsley 2020). Bioelectrical impedance (InBody) is fast and often free but least stable: it correlated with DEXA at 0.88 across 591 adults but overestimated body fat ~3-4.4 points in lean people and underestimated ~2.7-4.3 points in heavier people, with the error flipping direction across the range, and day-to-day readings move with hydration, food, and exercise (Sun 2005, AJCN). Practical rule: pick one method, one machine, same time of day, fasted, form-fitting clothing, and scan every 4-8 weeks, not weekly. On a GLP-1 a baseline scan is what makes follow-ups interpretable, since the scale can't tell fat loss from lean loss. Defiant runs a Styku 3D scan in Lisle, IL for $50 (about 30 seconds; included in Core Wellness membership credits), built into weight-loss and peptide protocols; it's a tracking tool, not a clinical diagnostic, and a DEXA at an imaging center is the call for a research-grade snapshot. Cites Bennett 2022, Sun 2005, Ramirez 2026, and Tinsley 2020. - [Does a GLP-1 Cause Hair Loss?](https://defianthealth.io/blog/does-glp-1-cause-hair-loss/): Yes, some people shed on semaglutide or tirzepatide, and it's usually temporary. The weight-management labels report hair loss in 3% of treated adults on semaglutide (vs 1% placebo; Wegovy label) and 5%/4%/5% at tirzepatide 5/10/15 mg (vs 1%; Zepbound label). The tirzepatide rate does NOT climb with dose (unlike vomiting, 8/11/13%), and the label states the hair loss 'was associated with weight reduction,' so the driver is fast weight loss, not the drug acting on hair. Classic telogen effluvium triggers (crash dieting, low protein, surgery, childbirth, fever, iron deficiency) fit. Huge sex split: 7.1% of women vs 0.5% of men on tirzepatide (1.3% vs 0% placebo), partly biology, partly visibility, partly care-seeking. Mechanism: ~85% of hair is growing / ~15% resting; stress can push up to 70% of growing hairs into the resting phase, which then shed 1-6 months later (avg ~3), so the shedding at month 3-5 traces to the steep calorie drop at month 1. Benign, reversible, no scarring; regrowth can take up to 6 months to restart. What helps: enough protein, a slower pace of loss (bi-weekly titration), and checking iron (iron saturation more sensitive than ferritin), zinc, vitamin D, and thyroid; most cases resolve on their own. What to skip: biotin (not a named deficiency), and minoxidil is unproven for telogen effluvium. Red flags for a dermatologist: patchy/circular bald spots, scaling/painful scalp, scarring, shedding past 6 months, or a temple/crown pattern (androgenetic alopecia). Observational GLP-1 cohorts can't separate drug from weight loss; the placebo-controlled label data is the cleaner read. Never self-adjust a dose. Honest note: the label data is for branded products; compounded versions (what many clinics, including Defiant, dispense) weren't in those trials. Defiant runs medically supervised weight loss in Lisle, IL from $295/mo with a $50 consult (separate from program cost), bi-weekly titration, monthly Styku scans, and nurse access. Cites the Wegovy and Zepbound FDA labels, StatPearls Telogen Effluvium, Vidal 2026 (JAAD Int), and Burke 2025 (JAAD). - [How Much Does Hyperbaric Oxygen Therapy Cost?](https://defianthealth.io/blog/hyperbaric-oxygen-therapy-cost/): Hyperbaric pricing splits into two markets that use the same machine. Hospital wound-care hyperbaric is a course of dozens of physician-supervised sessions billed to insurance, which is where the five-figure numbers online come from; it treats a diagnosis, not a recovery goal. Recovery/wellness clinics charge cash, per session: at Defiant in Lisle, IL a 30-minute session is $99, 60 minutes $185, 90 minutes $225, with a $49 first 30-minute session ($99 first 60-minute) for new clients, run in an OxyHealth 64D hard-shell multiplace chamber up to 2.0 ATA. What drives a wellness session's price: session length, chamber type/pressure (hard-shell ~2.0 ATA costs more than soft-shell ~1.3 ATA), staffing, and packages; a price far below the local range usually means a soft-shell chamber, lower pressure, or no staff present. Hyperbaric at Defiant is self-pay (no insurance, no HSA/FSA); a Premier membership ($150/mo) includes a monthly 60-minute session (Premium Recovery credit, vs $185 single) plus Core Wellness credits, with a 3-month commitment and 30-day credit expiry. The FDA has cleared HBOT for a specific list of medical conditions and states it is NOT proven for cancer, Lyme, autism, or Alzheimer's, warning against clinics that claim otherwise; recovery and general wellness are not cleared indications. Serves Naperville, Downers Grove, Wheaton, Bolingbrook, Lombard. Cites the FDA. - [How Many Microneedling Sessions Do You Need?](https://defianthealth.io/blog/how-many-microneedling-sessions/): Most skin goals take a series of three to six microneedling (collagen induction therapy) sessions spaced four to six weeks apart, not one. A 2018 Dermatologic Surgery review (Alster) calls three to six treatments standard and notes a lag of at least six to eight weeks before new collagen shows up as visible change. The fresh 'glow' at day three or four is inflammation and water retention, not collagen; the structural remodeling runs for months (histology: collagen I/III/VII increases after six sessions, El-Domyati 2015; considerable collagen/elastin deposition at six months and ~40% stratum spinosum thickening at one year across 480 patients, Aust 2008). Evidence is real but weak: a 2025 Aesthetic Plastic Surgery review (Foppiani, 21 studies, 723 patients) found 83% pooled satisfaction (95% CI 0.76-0.88) with mild, uncommon side effects (transient redness 6.8%, scaling 1.7%, burning 1.5%, itching 0.4%) but rated the overall level of evidence IV, not a randomized trial. For atrophic acne scars, a 2026 Cureus meta-analysis (Ilesanmi, 11 studies, 713 participants) found microneedling more likely than chemical peels to produce ANY measurable improvement (RR 1.79, 95% CI 1.37-2.34, p<0.0001) but no significant difference at the 50%-or-better threshold (RR 0.97, p=0.74) and a nonsignificant trend favoring peels on continuous scores (SMD -0.27, p=0.41). Sessions by goal: tone/glow ~3, texture/pores 3-4, fine lines 4-6, atrophic acne scars 5-6+, stretch marks 4-6. Session spacing is genuinely unsettled (two to six weeks, no head-to-head trial); Defiant uses four to six weeks so remodeling finishes between sessions. What pushes you to the high end: scar depth (ice-pick often needs a combined plan; active acne is treated first via Acne Bootcamp), age/baseline collagen, sun/SPF (unprotected sun raises post-inflammatory hyperpigmentation risk, more so in deeper skin tones), and optional boosters. Boosters, framed honestly: De|RIVE exosomes ($450) and PDGF ($650) are worked into the fresh channels and MAY help, but exosome products are NOT FDA-approved for skin treatment, the evidence is early, and no good evidence shows a booster shortens the series. Collagen isn't permanent (maintenance every 3-6 months). Pricing in Lisle, IL: $350/session, $450 with exosomes, $650 with PDGF, four-session exosome package $1,500, three-session PDGF package $1,755; a plain 3-6 session series runs $1,050-$2,100; members save. Session is 30-60 min with numbing cream, pink 1-3 days. Avoided over active breakouts/infection, certain skin conditions, and in pregnancy. Cites Alster 2018, El-Domyati 2015, Aust 2008, Foppiani 2025, and Ilesanmi 2026. - [Do B12 Shots Actually Work?](https://defianthealth.io/blog/do-b12-shots-work/): An honest answer: B12 shots work best when you're actually deficient, and that's where the evidence is strongest by far. In people whose levels are already normal, a 2021 meta-analysis of 16 RCTs and 6,276 participants (Markun) found no effect on cognition or depression and too little fatigue data to analyze; a 2026 Nutrients review (Yepes-Calderon) found benefit outside deficiency confined to narrow subgroups (elevated homocysteine, or low-normal B12 status), on single studies without replication. Prevalence: ~3.6% of US adults deficient under 200 pg/mL, ~12.5% insufficient under 300 pg/mL (NIH ODS). Deficiency is usually an absorption ('plumbing') problem, not diet: adults over 60 (atrophic gastritis 8-9% of 65+), metformin users (DPPOS: 4.3% vs 2.3% low at 5 years, 19.1% vs 9.5% low/borderline; Aroda 2016), long-term PPI/H2-blocker users, vegans/vegetarians, post gastric bypass, pernicious anemia (~151/100,000), and Crohn's/celiac. The liver stores 1-5 mg (about a three-year supply) so deficiency takes years to surface. Pills vs shots: a 2018 Cochrane review (3 small trials, 153 people, low-quality) found high-dose oral 1,000-2,000 mcg normalized serum B12 about as well as intramuscular injections, since ~1.3% of a 1,000 mcg dose absorbs by passive diffusion (no intrinsic factor needed); injections keep a real edge for pernicious anemia, post-surgical malabsorption, and severe deficiency, plus the practical certainty of one visit. B12 has no established upper intake limit, so risk is low, but that isn't the same as useful at any dose. B12 is NOT a weight loss treatment and, per Mayo Clinic, won't boost energy or performance unless you're low. Get a serum B12 (add MMA or homocysteine in the 200-300 gray zone). Defiant writes the lab order (sample collected at home with a Tasso device, not in-clinic) and offers B12 Energy+ at $50, same as every single vitamin shot, in Lisle, IL. Cites Markun 2021, NIH ODS, Yepes-Calderon 2026, Mayo Clinic, Aroda 2016, and the 2018 Cochrane review. - [What to Expect at Your First Medical Weight Loss Consultation](https://defianthealth.io/blog/first-medical-weight-loss-consultation/): A plain walkthrough of a first GLP-1 weight-loss consultation. It does two jobs: screening (a boxed warning for thyroid C-cell tumors means the provider must rule out personal or family history of medullary thyroid carcinoma or MEN 2, plus pregnancy, pancreatitis, and significant GI disease) and protocol design. Eligibility tracks the FDA-approved indication (adults with obesity, or overweight plus one weight-related condition), which in practice is BMI 30+, or 27+ with a condition like high blood pressure, type 2 diabetes, or sleep apnea (the STEP 1 entry criteria). What to bring: weight history, full medication and supplement list, past labs, and a specific goal. Bloodwork comes before the first dose (blood sugar/HbA1c, thyroid, kidney/liver, lipids); Defiant writes the order and you collect your sample at home with a Tasso device, a nearly painless collection from your own arm, so there is no lab visit. Every protocol starts with a Styku 3D body composition scan because some lean-mass loss happens with any weight loss and the scale hides it; body comp is tracked every 4 weeks and countered with protein and resistance training, not a medication change. Expectations, honest: STEP 1 semaglutide 2.4 mg averaged -14.9% over 68 weeks (Wilding 2021) and SURMOUNT-1 tirzepatide 15 mg -20.9% over 72 weeks (Jastreboff 2022), but real-world one-year semaglutide averaged just -5.1% (Gasoyan 2024, 3,389 patients), rising to -12.9% among those with persistent coverage treated for obesity, since only 40.7% stayed on treatment a full year, which is the case for a structured program over a prescription-by-mail. Questions to ask any clinic (titration cadence, who answers between visits, what's in the price, how progress is tracked, plateau plan, muscle-protection plan, stopping plan). Cost: $50 consultation, custom GLP-1 protocols from $295/mo (medication, provider oversight, bi-weekly titration, weekly nurse access, monthly scans), members save 20%; no insurance billing. Defiant runs it in Lisle, IL with telehealth follow-ups across Naperville and the western suburbs (initial scan in-clinic). Cites Wilding 2021 (STEP 1), Jastreboff 2022 (SURMOUNT-1), Gasoyan 2024, and the FDA semaglutide label. - [Sauna or Cryotherapy First?](https://defianthealth.io/blog/sauna-or-cryotherapy-first/): The sequencing question for contrast therapy, answered honestly. Standard order is heat first then cold, and that's what Defiant runs, but almost nobody has tested the reverse in a controlled trial, so the rule is convention plus practical reasoning, not a finding. The practical driver at Defiant: the cryotherapy chamber (Everest CryoBuilt, hard stop at 3:30) needs completely dry skin, so you sauna first and towel off before the chamber. Evidence base is a 2013 PLoS ONE systematic review of 18 controlled trials (all high risk of bias; 13 pooled): contrast water therapy beat passive rest for muscle soreness and strength loss at every follow-up from under 6 hours to 96 hours, but showed little advantage over cold water immersion, warm water immersion, compression, active recovery, or stretching, and the effect 'may be most relevant to an elite sporting population' (Bieuzen 2013). Ordering was never studied as a variable. Research protocols were short (1-min cold rounds, 1 to 3 min hot, 6 to 24 min total) and used water immersion, not a cryo chamber; a crossover study (Costello 2012) found -110C whole body cryotherapy and 8C cold water immersion cooled muscle and core similarly but cryo dropped skin temperature further. Start cold instead when the goal is to wake up (the quoted 530% noradrenaline / 250% dopamine spike is from a full hour in 14C water, Sramek 2000, not a 3.5-min cryo session), for heat-reactive skin, or when cryo is the main event. The one timing rule with strong evidence is unrelated to order: cold immediately after lifting blunted 12-week strength and muscle gains versus active recovery (Roberts 2015), so separate hard lifting from the cold if hypertrophy is the goal. Sample session and pricing: new-client $25 first cryo and $25 first 30-min sauna, single cryo $50, sauna from $45, at Defiant in Lisle, IL (serves Naperville, Downers Grove, Wheaton, Oak Brook). Pairs with the companion explainer on what contrast therapy is and whether it works. Cites Bieuzen 2013, Costello 2012, Sramek 2000, and Roberts 2015. - [Are GLP-1s Good for Your Heart?](https://defianthealth.io/blog/glp-1-and-heart-health/): An honest read on GLP-1s and cardiovascular health. For one specific group the answer is a well-documented yes: in the SELECT trial (Lincoff 2023, NEJM), 17,604 adults with established cardiovascular disease and overweight or obesity but NO diabetes had major adverse cardiovascular events fall from 8.0% to 6.5% on semaglutide 2.4 mg over a mean 40 months (HR 0.80, 95% CI 0.72-0.90), and on that basis the FDA approved semaglutide 2.4 mg in March 2024 to reduce cardiovascular risk in that population, the first weight-management drug to carry a cardiovascular indication. Key caveats the headlines drop: every participant was a secondary-prevention case (prior heart attack, stroke, or symptomatic peripheral artery disease, age 45+), 88% were on a statin the whole time, and cardiovascular death taken alone did NOT reach significance (HR 0.85, p=0.07), though all-cause death (HR 0.81) and nonfatal MI (HR 0.72) did. Tirzepatide's data differs and is not directly comparable: SURPASS-CVOT (Nicholls 2025) tested it against dulaglutide, not placebo, in 13,165 people with type 2 diabetes and heart disease and cleared noninferiority (12.2% vs 13.1%, HR 0.92, p=0.003) but missed superiority (p=0.09); SUMMIT (Packer 2025) found tirzepatide cut cardiovascular death or worsening heart failure from 15.3% to 9.9% in 731 adults with HFpEF and obesity. Whether the benefit is the drug or the weight loss is unresolved (weight fell 9.4%, systolic BP dropped ~3.3 mm Hg more than placebo, progression to HbA1c 6.5%+ was 3.5% vs 12.0%). None of it has been shown to prevent heart attacks in people without existing cardiovascular disease. The FDA cardiovascular indication covers the branded FDA-approved product, NOT compounded semaglutide; the class also carries an FDA boxed warning for thyroid C-cell tumor risk, and resting heart rate rises a mean 1 to 4 bpm (label). Defiant runs medically supervised weight loss in Lisle, IL ($295/mo) with a provider consult, lab orders (sample collected at home with a Tasso device, not in-clinic), monthly Styku scans, and bi-weekly titration. Cites Lincoff 2023 (SELECT), the FDA 2024 approval, Nicholls 2025 (SURPASS-CVOT), Packer 2025 (SUMMIT), Deanfield 2024 (SELECT heart-failure analysis), and the semaglutide prescribing information. - [What to Expect at Your First HBOT Session](https://defianthealth.io/blog/what-to-expect-first-hbot-session/): A minute-by-minute walkthrough of a first hyperbaric oxygen therapy session. The only demanding part is the 3 to 8 minute pressurization phase, when the chamber climbs toward 2.0 ATA and your ears must equalize like on a plane (yawn, swallow, or hold your nose and swallow); middle-ear barotrauma is the most common side effect, reported at 10.04% in a 2,610-patient five-year analysis (Edinguele 2020), highest during the first sessions and usually mild. A 2017 review (Heyboer) calls HBOT among the safest therapies used today; oxygen-toxicity seizures run about 1 in 2,000 to 3,000 treatments and temporary nearsightedness affects 20 to 40% of people only after 20+ daily sessions, exposures far beyond a single 30-minute visit. Claustrophobia is chamber-dependent: monoplace hospital tubes drive confinement anxiety (about 8 events per 10,000 treatments) while Defiant's hard-shell OxyHealth 64D multiplace unit seats two upright with clear walls. Wear 100% cotton, leave all electronics and metal out, skip lotions and petroleum products (fire risk in high oxygen). Contraindications (Cleveland Clinic): untreated pneumothorax, COPD/emphysema/cystic fibrosis, current cold or fever, recent ear injury or surgery, and pregnancy outside emergency carbon monoxide poisoning. Honest scope: the FDA has cleared HBOT for a specific list (carbon monoxide, decompression sickness, gas embolism, gas gangrene, crush injuries, non-healing wounds, radiation injury, severe anemia, compromised skin grafts, sudden hearing or vision loss) and states it is NOT proven for cancer, Lyme, autism, or Alzheimer's; recovery and general wellness use is not a cleared indication. Defiant runs the OxyHealth 64D (2.0 ATA, seats two) in Lisle, IL: 30/60/90-minute sessions $99/$185/$225, $49 first session. Cites Heyboer 2017, Edinguele 2020, Cleveland Clinic, and the FDA. - [What Is a Myers Cocktail IV?](https://defianthealth.io/blog/what-is-a-myers-cocktail-iv/): An honest explainer on the Myers Cocktail, an IV drip of magnesium, calcium, B vitamins (B12, B6, B5, B-complex), and vitamin C, run over 15 to 30 minutes. Named after Baltimore physician John Myers, MD (d. 1984) and published in modern form by Alan Gaby, MD, in a 2002 Alternative Medicine Review paper drawn from ~15,000 treatments over 11 years, in which Gaby himself said only a small amount of published research supports it. The single randomized placebo-controlled trial (Ali 2009, n=34 fibromyalgia patients) found no statistically significant benefit over a lactated Ringer's placebo; the Merck Manual says there is insufficient evidence IV vitamin therapy produces the effects it's marketed for; a 2023 Drug and Therapeutics Bulletin review found no high-quality benefit evidence absent a deficiency or medical indication. IV delivery does reach far higher blood levels than oral (Padayatty 2004: 1.25g vitamin C = ~135 umol/L oral vs ~885 umol/L IV), but higher levels have not been shown to help people who weren't deficient. People often feel better from fluid, magnesium, correcting a real deficiency, or placebo. IV nutrients clearly help in documented deficiency, malabsorption (Crohn's, celiac, post-bariatric), and dehydration. Honest framing: a drip may support hydration and how you feel that day, and is not a treatment for any illness; it won't cure a hangover. Covers safety (magnesium can drop blood pressure; caution with kidney disease, abnormal electrolytes, heart rhythm conditions; pregnancy safety not studied) and questions to ask any clinic. Defiant offers IV drips ($185) and vitamin shots ($50) in Lisle, IL, walk-ins welcome, and points fatigue toward bloodwork first. Cites Gaby 2002, Ali 2009, the Merck Manual, Padayatty 2004, and the 2023 Drug and Therapeutics Bulletin review. - [The Best Peptides to Pair With Tirzepatide](https://defianthealth.io/blog/peptides-to-take-with-tirzepatide/): An honest answer to which peptides to take or pair with tirzepatide (or any GLP-1). The short version: no peptide has been proven to make tirzepatide work better, and no study has ever tested a peptide and a GLP-1 taken together, so 'stacks' promising more are ahead of the evidence. The real reason people ask is muscle loss: a meaningful share of the weight lost on a GLP-1 can be lean mass if it isn't protected (Sargeant 2019), and the best-supported ways to protect it are adequate protein and resistance training plus body-composition tracking, not peptides (Santic 2026 Metabolites; Cava 2017). Among peptides, the growth-hormone-axis compounds (tesamorelin, sermorelin, ipamorelin) have the most human data, led by tesamorelin, which is FDA-approved only to reduce visceral abdominal fat in HIV-associated lipodystrophy (Falutz 2010), an off-label, provider-decided use if applied alongside a GLP-1. BPC-157 is framed educationally: animal studies show real signals for tendon, muscle, and gut tissue repair, but there are no completed human trials and it is not FDA-approved, so it sits in an early, unproven spot (Sikiric 2024). Every peptide is a provider decision made after bloodwork, considered only once the basics are in place. Defiant runs medically supervised weight-loss protocols in Lisle, IL ($295/mo) with labs, monthly Styku scans, and bi-weekly titration, and offers peptide therapy (including tesamorelin) prescribed only after a consult. Cites Sargeant 2019, Santic 2026, Cava 2017, Falutz 2010, and Sikiric 2024. - [How Long Should You Stay in an Infrared Sauna?](https://defianthealth.io/blog/how-long-should-you-stay-in-an-infrared-sauna/): How long to stay in an infrared sauna, and why 15 to 30 minutes is the honest ceiling on what the research can tell you. A 2018 systematic review (Hussain & Cohen, 40 studies, 3,855 participants, 25 infrared) found nearly all infrared studies ran 15 to 30 minutes at about 60C (140F); only 13 of the 40 were randomized controlled trials and the review calls optimal duration an open question. Beginners should start at 10 to 15 minutes and build across visits. For post-workout recovery, a 2023 trial (Ahokas, n=16 basketball players) used a single 20-minute infrared session at 43C after resistance training and saw less soreness, better-preserved jump performance, and no harm to overnight heart rate variability. The widely quoted 19-minute figure comes from a 21-year observational study of 2,315 Finnish men using TRADITIONAL saunas at 80 to 90C (Laukkanen 2015, JAMA Internal Medicine): sessions over 19 minutes were associated with 52% lower sudden-cardiac-death risk (HR 0.48) versus under 11 minutes, but it is observational, in a specific population, and a JAMA correspondence (Kivimaki 2015) argued the link may be noncausal, so it does not translate to an infrared cabin. A 2018 Mayo Clinic Proceedings review concluded regular sauna bathing may support cardiovascular and other outcomes, best discussed with a physician first. Covers building heat tolerance, when to get out (dizziness, nausea, headache, irregular heartbeat, or stopping sweating while hot), hydration (sauna sweat is water weight, NOT weight loss or detox), and who should be careful (pregnancy, unstable angina, low or uncontrolled blood pressure, diuretics, impaired heat sensation; never combine alcohol and sauna). Defiant runs a Radia IR 300 hybrid cabin in Lisle, IL that does infrared (~130F) or Finnish-style dry heat (~200F): 30/45/60-minute sessions at $45/$65/$85, $25 first session; also a Core Wellness membership credit and pairs with cryotherapy as contrast therapy. Cites Hussain & Cohen 2018, Ahokas 2023, Laukkanen 2015, Laukkanen 2018, and Kivimaki 2015. - [Do GLP-1s Reduce Inflammation?](https://defianthealth.io/blog/glp-1-and-inflammation/): Yes, GLP-1s substantially lower inflammation markers in major trials, but the honest question is whether that's a direct drug effect or just what happens when you lose weight. C-reactive protein (CRP), a liver protein that rises with inflammation and is easy to measure on a blood test, fell versus placebo by 44%/39%/48% at week 68 across the STEP 1/2/3 semaglutide 2.4 mg trials (Verma, eClinicalMedicine 2023), and in a SURMOUNT-1 tirzepatide analysis (Sattar, JACC 2026, n=392) placebo-adjusted CRP dropped 36.9/46.9/54.6% and IL-6 25.4-30.2% at 72 weeks, alongside improvements in insulin resistance, leptin, and adiponectin. A pooled 2026 review (Masson) put the average CRP drop at 32.9% and IL-6 at 17.8%. On causation the draft is deliberately honest: CRP change correlated most strongly with bodyweight change, an earlier phase 2 CRP effect lost significance after adjusting for weight, a SUSTAIN/PIONEER mediation analysis (Mosenzon 2022) attributed 20.6-61.8% of the CRP effect to blood sugar and bodyweight together, and the semaglutide authors themselves wrote whether there's a weight-independent effect 'remains to be determined.' Explicitly states these drugs are NOT approved to treat inflammatory or autoimmune conditions (rheumatoid arthritis, IBD), that a falling hsCRP is a biomarker moving and not a disease being treated, and that all cited trials were manufacturer-funded. Defiant's medically supervised weight-loss program in Lisle, IL ($295/mo) writes lab orders (hsCRP is an easy, cheap add), does monthly Styku body composition scans, and titrates every two weeks. Cites Verma 2023, Sattar 2026, Mosenzon 2022, and Masson 2026. - [How Often Should You Do Cryotherapy?](https://defianthealth.io/blog/how-often-should-you-do-cryotherapy/): Why the honest answer to how often to do whole body cryotherapy depends on your goal, and why three different frequencies float around. For recovery after one hard session or event, the 2021 cryostimulation consensus paper (Bouzigon, Front Sports Act Living) recommends a tight cluster of 1 to 5 sessions with at least two inside the first 24 hours, then stop; a 2023 cryosauna RCT (Wolska, 31 participants) used four sessions at -110C for 90 seconds at 0/24/48/72h and saw lower creatine kinase and less stiffness. For general wellness use, 2 to 3 sessions a week is common practice but NO randomized trial has established an optimal weekly frequency. Clinical and inflammatory protocols run far denser, often 10 to 20 consecutive daily sessions. The largest synthesis, a 2026 network meta-analysis of 51 RCTs and 1,243 people (Wu, Front Sports Act Living), found whole body cryotherapy best for markers of muscle damage at 48 and 72 hours but with limited impact on delayed-onset muscle soreness (DOMS) itself, where it ranked last at 48h; cold water immersion won for fast pain relief in the first hour, so match the method to the goal and timing. A 2015 Cochrane review (4 trials, 64 adults) found insufficient, very-low-quality evidence that WBC reduces soreness versus rest. Also covers habituation (the cold shock fades with repeated use, so use cryo in defined blocks rather than indefinitely at the same dose), the lifting caveat (regular cold right after resistance training may blunt strength and muscle-size gains, though this is mostly cold-water-immersion research and WBC did not impair judo athletes when done ~2h after training), who should be careful (unstable angina, advanced heart failure, cardiovascular caution; cold hives and cold burns are the common side effects), and that whole body cryotherapy is NOT FDA-cleared to treat any condition. Defiant runs an Everest CryoBuilt chamber in Lisle, IL (up to 3:30, around -200F): $25 first session, $50 single, $299 unlimited monthly, and a Core Wellness credit in all three membership tiers; pairs with the infrared sauna as contrast therapy. Cites the Bouzigon 2021 consensus paper, Costello 2015 Cochrane review, Wolska 2023, and Wu 2026. - [Why GLP-1s Can Make You So Tired](https://defianthealth.io/blog/glp-1-fatigue/): Why fatigue is one of the most common non-stomach GLP-1 side effects and why it usually traces to something fixable rather than the drug itself. Fatigue (including asthenia) was reported by 11% of adults on semaglutide 2.4 mg versus 5% on placebo, and 5%/6%/7% on tirzepatide 5/10/15 mg versus 3% (FDA WEGOVY and ZEPBOUND labels; the two are separate trials, not a head-to-head). The four usual drivers are an unintentionally steep calorie deficit (appetite suppression mutes the hunger signal that would flag it), low protein intake, mild dehydration (also the mechanism behind rare postmarketing acute kidney injury reports, which the tirzepatide label ties to GI adverse reactions causing dehydration), and low micronutrients. A February 2026 Clinical Obesity review of 480,825 GLP-1 users (Urbina 2026) found vitamin D deficiency in 13.6% at 12 months, nutritional anemia 4%, iron deficiency 3.2%, and B vitamin deficiency 2.6%; a 69-person food-record arm found 64% under the iron target and only 1.4% meeting vitamin D. Fatigue tends to peak in the first weeks and for a few days after each dose increase. Fixes: eat and drink on a schedule rather than on cues, front-load protein, add electrolytes, get labs (vitamin D, ferritin, B12, CBC) rather than guessing at supplements, and resistance train to protect lean mass (protein + resistance training are the best-supported levers, Metabolites 2026). Deliberately gives NO dose-adjustment guidance and routes dose questions to the provider. Red flags for a provider: worsening fatigue, vomiting/diarrhea preventing fluids, lightheadedness or reduced urination, or sudden episodes on insulin or a sulfonylurea. Defiant runs medically supervised GLP-1 protocols from $295/mo in Lisle, IL with labs, monthly Styku scans, bi-weekly titration, and nurse access. Cites the FDA WEGOVY and ZEPBOUND labels, Urbina 2026 (Clinical Obesity), and Santic 2026 (Metabolites). - [How Long Does It Take to Clear Acne?](https://defianthealth.io/blog/how-long-does-it-take-to-clear-acne/): How long acne actually takes to clear and why nearly everyone quits too early. Most treatments need about 12 weeks before you can fairly judge them, the standard evaluation window in the 2024 American Academy of Dermatology acne guidelines (Reynolds 2024) and in most of the randomized trials behind them; first visible change is typically weeks 4 to 8. The reason for the delay is biological: visible pimples begin as invisible microcomedones weeks earlier (they have to be lifted off the skin with cyanoacrylate stripping to be counted, Fontao 2020), so the first several weeks of any regimen are spent clearing a backlog that was already forming. Weeks 3 to 6 are the hardest stretch, mixing retinoid irritation with lesions surfacing on a compressed schedule; a review of trial data found no evidence topical retinoids truly cause a flare (Yentzer 2009). Dark marks (post-inflammatory hyperpigmentation) run on a separate, slower clock, roughly 6 to 12 months for epidermal pigment and longer when it sits deeper (Kaufman 2018), while true atrophic scarring is a texture problem addressed later with microneedling. Includes a realistic week-by-week model, what makes clearing take longer (starting and stopping, escalating too fast, treating the wrong driver, picking, no maintenance plan), and how Defiant's Acne Bootcamp uses 6-to-12-week structure and check-ins in Lisle, IL ($100 acne consultation). Cites the 2024 AAD acne guidelines, Fontao 2020, Kaufman 2018, and Yentzer 2009. - [Why Adult Acne Doesn't Respond to Teen Acne Products](https://defianthealth.io/blog/adult-acne-treatment-bootcamp/): Why adult acne is a different problem than teenage acne and why the drugstore products built for oily teen skin often make it worse. Adult acne, especially in women, is more closely linked to hormones and inflammation than to the excess oil and clogged pores that drive most teen acne (Telkkala 2025); it is common and persistent, with reported prevalence in adult women ranging from about 12 to 54 percent and most cases carrying over from adolescence rather than starting fresh, roughly 77 percent persistent in one review (Bagatin 2019). High-strength benzoyl peroxide, strong acids, and alcohol-heavy toners can strip and inflame drier, more reactive adult skin, and stacking actives without a plan inflames the barrier further. What tends to help: addressing the cause rather than just the surface, protecting the skin barrier, sequencing actives instead of stacking them, using in-clinic treatments where they help, and staying consistent over weeks to months. Describes Defiant's Acne Bootcamp in Lisle, IL, a structured multi-week program combining a matched topical routine, in-clinic treatments, and accountability check-ins, starting with a $100 consultation, serving Naperville, Downers Grove, Wheaton, Oak Brook, and Chicago's western suburbs. Cites Telkkala 2025 (Health Science Reports) and Bagatin 2019 (Anais Brasileiros de Dermatologia). - [Body Composition on a GLP-1: Why the Scale Only Tells You Half the Story](https://defianthealth.io/blog/body-composition-on-glp-1/): Why the bathroom scale only tells half the story on a GLP-1 - what you lose is a mix of fat, lean tissue, and water, and the ratio matters more than the number. The clearest data comes from DXA body composition substudies: SURMOUNT-1 (tirzepatide, n=160, 72 weeks) found body weight down 21.3%, fat mass down 33.9%, lean mass down 10.9%, about 75% fat and 25% lean, the SAME proportion in the placebo group, so lean loss reflects weight loss in general rather than a medication effect (Look 2025). STEP 1 (semaglutide, n=140) reported total fat down 19.3% and visceral fat down 27.4%, with lean mass rising as a share of body weight (Wilding, ENDO 2021). Some lean loss happens in essentially any significant weight loss; GLP-1s make it easier to under-eat protein, which is fixable. The 2026 SEMALEAN study (n=106, BMI 46) found handgrip strength IMPROVED 4.5 kg over 12 months and sarcopenic obesity fell from 49% to 33%, so lean-mass loss and functional decline are separate questions. Defiant tracks body composition monthly with a Styku 3D optical scan (not DXA, but consistent for trend tracking) in Lisle, IL: $50 per scan, $25 new client, included monthly in the $295/mo weight-loss program. Cites the STEP 1 and SURMOUNT-1 DXA substudies and the SEMALEAN study. - [GLP-1 Injection Sites: Where to Inject and Why Rotation Matters](https://defianthealth.io/blog/glp-1-injection-sites/): Where to inject a GLP-1 (semaglutide or tirzepatide) and why site rotation matters more than which region you pick. The three FDA-approved subcutaneous sites are the abdomen (staying about two inches from the navel), the front or outer thigh, and the back of the upper arm; the FDA prescribing information for both compounds reports similar drug exposure across all three, so absorption is not a reason to favor one. Abdominal fat has slightly higher blood flow, but these drugs are slow-release (tirzepatide peaks about 8 to 72 hours after a dose, semaglutide about 1 to 3 days), which smooths out the difference. Rotating the exact spot each week helps prevent lipohypertrophy, a firm fatty buildup linked to erratic absorption; in insulin users (Blanco 2013, n=430) 64.4% had it and 98% of those were not rotating or rotated incorrectly, versus 5% among correct rotators. Includes a simple abdomen-quadrant rotation system, where NOT to inject (bruised, scarred, or lumpy skin; within two inches of the navel; non-approved sites), what is normal afterward versus when to call a provider, and how Defiant runs in-clinic injection training with bi-weekly check-ins in Lisle, IL ($295/mo). Cites the FDA semaglutide and tirzepatide labels, Blanco 2013, the NCT04050670 tirzepatide injection-site trial, and FDA sharps-disposal guidance. - [How Many HBOT Sessions Do You Need?](https://defianthealth.io/blog/how-many-hbot-sessions/): Why there is no single answer to how many hyperbaric oxygen therapy sessions you need. FDA-cleared medical indications (decompression sickness, carbon monoxide poisoning, gas gangrene, non-healing diabetic foot ulcers, delayed radiation injury, compromised skin grafts, thermal burns) run long, daily, physician-managed courses in accredited facilities, e.g. 30 to 40 daily sessions at 2.0 to 2.5 ATA for a diabetic foot ulcer (Londahl 2012). Recovery and general wellness use is NOT an FDA-cleared indication and the evidence is thinner: a 2021 meta-analysis (Huang) found no significant effect of pre- or post-exercise HBOT on performance or recovery, DOMS trials are consistently negative (Mekjavic 2000), soft-tissue injury reviews used roughly 3 to 10 session blocks, and a small 2020 telomere trial (Hachmo, n=35, aged 64+) used 60 daily 90-minute sessions at 2 ATA. Practical recovery starting point: a 5 to 10 session block over two to four weeks tracking specific markers, since repeated exposure in a compressed window is the common thread. Covers session length vs count, middle-ear barotrauma and contraindications (pneumothorax, bleomycin), the August 2025 FDA device-safety letter, and that HBOT is NOT cleared for Long COVID, TBI, autism, or stroke. Defiant runs an OxyHealth 64D (2.0 ATA, seats two) in Lisle, IL: 30/60/90-minute sessions $99/$185/$225, $49 first session, monthly hyperbaric credit in the Premier and Elite memberships. Cites StatPearls, Londahl 2012, Hachmo 2020, Huang 2021, Mekjavic 2000, and the FDA. - [NAD+ IV Therapy: What It Is and What It May Support](https://defianthealth.io/blog/nad-iv-therapy-benefits/): What NAD+ IV therapy is and what the evidence actually supports. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in every cell for energy metabolism, DNA repair (PARP enzymes), and the sirtuins; levels decline with age in human tissue (Massudi 2012). The strongest human evidence is for oral precursors like nicotinamide riboside, which reliably raise blood NAD+ and are well tolerated (Trammell 2016; Martens 2018 found ~60% higher NAD+ over six weeks plus a blood-pressure and arterial-stiffness signal in those with elevated readings). Direct IV NAD+ outcome data is still early; a pilot infusion study found plasma NAD+ did not rise until after about two hours (Grant 2019), which is why IV sessions run long and slow (flushing or chest tightness if pushed too fast). Framed honestly as a supportive longevity tool, NOT a proven treatment for aging, addiction, or neurodegenerative disease. Compares IV infusion vs subcutaneous injection and covers Defiant's options in Lisle, IL (injections $50 / $95 / $355; IV priced in-clinic; Niagen Longevity+ nicotinamide riboside shot). Cites Massudi 2012, Trammell 2016, Martens 2018, and Grant 2019. - [Sculptra vs Radiesse: How Biostimulator Fillers Compare](https://defianthealth.io/blog/sculptra-vs-radiesse/): How the two main biostimulator (collagen-stimulating) fillers differ. Sculptra is poly-L-lactic acid (PLLA): it adds no immediate volume and builds gradually over about three to six months across a series of sessions, lasting around two years, and best suits broad, diffuse volume loss. Radiesse is calcium hydroxylapatite (CaHA): its gel carrier gives immediate volume plus collagen stimulation over time, it typically lasts about twelve to eighteen months, and it suits contouring and structure like the jawline. Both differ from hyaluronic acid fillers (Juvederm, Restylane), which add instant, reversible volume; neither biostimulator is dissolvable, so injector experience and an in-person assessment matter. Includes Defiant's pricing in Lisle, IL (Sculptra $600 per vial; Radiesse $900 per vial, or $700 per vial for two or more) and a consult-first approach. Cites StatPearls (poly-L-lactic acid), the Breithaupt and Fitzgerald collagen-stimulators review, and the FDA soft-tissue fillers page. - [Tirzepatide for Sleep Apnea: What the Research Shows](https://defianthealth.io/blog/tirzepatide-for-sleep-apnea/): In December 2024 tirzepatide became the first prescription drug FDA-approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Covers the SURMOUNT-OSA phase 3 trial (Malhotra, NEJM 2024): the apnea-hypopnea index (AHI) dropped by about 25 events per hour without CPAP and about 29 with CPAP after a year, roughly 43 to 51 percent of participants reached remission or mild non-symptomatic apnea (versus about 14 to 15 percent on placebo), and most lost about 18 to 20 percent of body weight. Explains that the benefit tracks with weight loss reducing fat around the airway rather than a direct throat effect, that it is not a replacement for a sleep study or (in many cases) CPAP, and that a diagnosis comes first. Notes semaglutide is not separately FDA-approved for OSA. Describes Defiant's medically supervised GLP-1 program in Lisle, IL ($295/mo, bloodwork, Styku scans, bi-weekly titration). Cites the FDA approval announcement and SURMOUNT-OSA in the New England Journal of Medicine. - [Food Sensitivity vs Allergy Testing: The Difference](https://defianthealth.io/blog/food-sensitivity-vs-food-allergy-testing/): The difference between a food allergy and a food sensitivity, and why the tests are not interchangeable. A food allergy is an IgE-mediated reaction (fast, sometimes anaphylactic) diagnosed with skin prick tests, specific IgE blood work, and a supervised oral food challenge as the gold standard; a food sensitivity or intolerance is usually a delayed, digestive, non-dangerous reaction (lactose, FODMAPs, histamine). Most direct-to-consumer sensitivity panels measure IgG (sometimes IgG4), which the AAAAI, EAACI, and CSACI all advise against as a diagnostic tool because a high IgG level often just means you eat and tolerate that food. Frames an IgG panel as a hypothesis-generating starting point for provider-guided elimination and reintroduction, not a diagnosis. Notes that ~10.8% of US adults have a convincing food allergy while ~19% believe they do (Gupta 2019). Defiant offers an IgG Food Sensitivity Panel (250 foods, $300), an IgE Allergy Test (150 allergens, $200), and a Combo Panel (250 markers, $400) in Lisle, IL; samples are collected at home with a Tasso device, not in-clinic. Cites AAAAI, the EAACI Task Force report (Stapel 2008), the CSACI position statement (Carr 2012), NIAID, and Gupta 2019 (JAMA Network Open). - [Loose Skin After GLP-1 Weight Loss: What Helps](https://defianthealth.io/blog/loose-skin-after-glp-1-weight-loss/): Why loose skin after GLP-1 weight loss comes from the weight coming off, not the medication itself. Covers what drives it (age, total amount lost, how long the weight was carried, speed of loss, and lost muscle), why protecting lean mass matters most (in the STEP 1 body composition substudy, fat mass fell about 19.3% and roughly 40% of the total weight lost came from lean tissue), what may reduce it (a steady pace, protein and resistance training, hydration, not smoking, and giving skin one to two years to remodel), what helps once skin is already loose (microneedling for mild laxity, surgical body contouring for significant excess skin), and why the face can look older after major weight loss. Explains how Defiant builds muscle preservation into its GLP-1 program in Lisle, IL with bi-weekly titration and monthly Styku scans. Cites the STEP 1 body composition analysis, Light 2010, Atiyeh 2021 microneedling review, and Valente 2018 facial-age study. - [Hard-Shell vs Soft-Shell Hyperbaric Chamber: What Actually Matters](https://defianthealth.io/blog/hard-shell-vs-soft-shell-hyperbaric-chamber/): The two things that separate hyperbaric chambers: hard-shell (rigid, 2.0-3.0 ATA, the FDA-cleared medical range) versus soft-shell (flexible zip-up, ~1.3-1.5 ATA, general-wellness exemption), and monoplace (one person, pure oxygen) versus multiplace (two or more, compressed air breathed through a mask or hood). Pressure is the active ingredient, so the hard vs soft gap matters most; monoplace and multiplace deliver comparable therapy. Relays the FDA caution that HBOT devices are cleared only for specific uses (not cancer, Lyme, autism, or Alzheimer's) and to use HBOT under medical oversight. Defiant runs a hard-shell chamber in Lisle, IL that seats two, reaches up to 2.0 ATA, is medically supervised, with a $49 new-client first session. Cites StatPearls Hyperbaric Physics and the FDA HBOT device safe-use letter. - [Laser Hair Removal: How Many Sessions You Actually Need](https://defianthealth.io/blog/laser-hair-removal-sessions/): Why laser hair removal takes a series of about six to eight sessions spaced six to eight weeks apart, because the laser only disables follicles in their active growth phase (only about 20% at any given time). Covers how the laser targets follicle pigment and heats it, what to expect session by session (a 10-25% reduction after the first treatment, shedding over one to three weeks, the bigger shift by session three or four), why it is permanent hair reduction rather than removal, how candidacy depends on hair color, thickness, and skin tone, and Defiant's package pricing in Lisle ($99-$499 single session, $450-$1,200 packages). Cites StatPearls, Cleveland Clinic, and the American Academy of Dermatology. - [Do You Qualify for a GLP-1? How Eligibility Works](https://defianthealth.io/blog/do-you-qualify-for-glp-1/): Who qualifies for a GLP-1 like semaglutide or tirzepatide. Covers the FDA eligibility criteria (a BMI of 30 or higher, or 27 or higher with a weight-related condition such as prediabetes, high blood pressure, high cholesterol, or obstructive sleep apnea), why BMI is only a screen (body composition matters more), the contraindications (personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis, gallbladder disease, gastroparesis, pregnancy), and how a Defiant provider confirms eligibility with health history, labs, and a Styku body composition scan in Lisle, IL. Cites the FDA tirzepatide (Zepbound) approval and the Wegovy boxed warning. - [What Is a GLP-1 Titration Schedule?](https://defianthealth.io/blog/glp-1-titration-schedule/): How a GLP-1 dose climbs from a low introductory dose to a maintenance dose, the FDA-labeled four-week escalation steps for semaglutide and tirzepatide, why the slow ramp controls side effects, and how bi-weekly titration paces the climb. Cites SURMOUNT-1, STEP-1, and FDA labels. - [Why Your GLP-1 Weight Loss Hit a Plateau](https://defianthealth.io/blog/glp-1-weight-loss-plateau/): Why GLP-1 weight loss plateaus happen and what actually helps. Covers a real plateau vs a normal weekly fluctuation, the dose-response curve, muscle loss, drifting habits, and the metabolic set point, plus how bi-weekly titration and body composition scans guide the fix. Cites the SURMOUNT-1 plateau-timing analysis (Horn 2025) and STEP 1. - [Why GLP-1 Medications Quiet the Food Noise](https://defianthealth.io/blog/glp-1-food-noise/): What "food noise" is (the constant intrusive mental chatter about eating) and why GLP-1 medications like semaglutide and tirzepatide may quiet it. Covers GLP-1 receptors in the hypothalamus and reward pathways, appetite vs reward effects, why it's biology rather than willpower, and when food noise returns (plateau or stopping). Cites Drucker 2018, STEP 1, and SURMOUNT-1. - [How to Manage GLP-1 Side Effects](https://defianthealth.io/blog/how-to-manage-glp-1-side-effects/): The common GLP-1 side effects (nausea, constipation, diarrhea, vomiting), why they happen (slowed gastric emptying), how long they last, practical management, and why slow bi-weekly titration reduces them. Cites SURMOUNT-1 and STEP-1. - [Contrast Therapy: How Sauna and Cryotherapy Work Together](https://defianthealth.io/blog/contrast-therapy-sauna-cryotherapy/): How alternating sauna heat and whole-body cryotherapy works as a circulation pump for recovery, what the research (contrast water therapy meta-analysis, sauna mortality study) supports, session structure, and how Defiant runs it in Lisle. - [Whole Body Cryotherapy: What It Is and What to Expect](https://defianthealth.io/blog/whole-body-cryotherapy/): What whole body cryotherapy is (a two to three minute exposure to -200°F to -240°F cold air in an Everest CryoBuilt chamber), what the research suggests about recovery, soreness, and inflammation, the honest limits (2015 Cochrane review found insufficient evidence, not FDA-approved to treat any condition), what a session feels like, and how it compares to a cold plunge. Cites Rose 2017, Lombardi 2017, Costello Cochrane 2015, and the FDA. - [Sauna for Sleep: What the Research Actually Says](https://defianthealth.io/blog/sauna-for-sleep/): Whether a sauna before bed helps you sleep, and why it works through the body-temperature drop that follows the session rather than the heat itself. Research suggests passive body heating at 104-109°F, finished 60-120 minutes before bed, may shorten sleep onset by roughly 10 minutes; the Global Sauna Survey (n=482) found 83.5% reported better sleep. Covers timing, infrared vs dry heat, dosing, and who should be careful. Cites Haghayegh 2019 (Sleep Medicine Reviews), the Global Sauna Survey, and Laukkanen 2015 (JAMA Internal Medicine). - [IV Therapy in Lisle, IL: What's Actually in the Drip](https://defianthealth.io/blog/iv-therapy-lisle/): What IV therapy is (an in-clinic infusion of saline plus vitamins, minerals, and antioxidants that raises absorption vs pills), what each ingredient may support, and what the evidence does and doesn't show. Strongest for hydration and correcting a real deficiency; energy, immune, and glutathione "glow" benefits are plausible but less proven. Explains the Myers Cocktail, IV drips vs vitamin shots, and pushes back on "detox drip" marketing. At Defiant in Lisle: vitamin shots $50 (buy one, others 50% off), IV drips $185 each, walk-ins welcome; NAD+ priced separately. Cites Padayatty & Levine 2016 and Gaby 2002. - [Sermorelin vs Tesamorelin: What's the Difference?](https://defianthealth.io/blog/sermorelin-vs-tesamorelin/): How the two GHRH peptides compare. Both prompt the pituitary to release your own growth hormone in a natural pulse; sermorelin is the gentler short fragment framed for sleep, recovery, and general longevity, while tesamorelin is a stabilized, more potent analog FDA-approved to reduce visceral fat in HIV-associated lipodystrophy (about 15% over 26 weeks). Neither is a weight-loss drug; both are prescription-only and medically supervised. Cites Falutz 2007 (NEJM), Sigalos 2018, and the FDA EGRIFTA label. - [What to Eat on a GLP-1: A Simple, Protein-First Guide](https://defianthealth.io/blog/what-to-eat-on-glp-1/): A practical eating guide for semaglutide and tirzepatide. Lead with protein (many providers suggest 1.2 to 1.6 g/kg/day), eat smaller portions slowly, stay ahead of hydration and fiber, and know which foods (fried, greasy, very sweet, carbonated, large fast meals) tend to trigger nausea. Covers protecting lean muscle with protein plus resistance training, a sample day of eating, and common mistakes. Cites STEP 1, Leidy 2015, and Almandoz 2024. - [NAD+ Injection vs IV: Which One Is Right for You?](https://defianthealth.io/blog/nad-injection-vs-iv/): How subcutaneous NAD+ injections compare with NAD+ IV infusions on absorption, cost, comfort, and use. IV gives near-complete bioavailability and a large single rise in plasma NAD+ (~400% in a 6-hour pilot infusion) but takes hours; injections deliver a smaller share per dose but are quick, cheaper, and easy to repeat for a steady rhythm. NAD+ is framed as a supportive longevity tool, not a treatment or anti-aging cure. Cites Schultz & Sinclair 2016, Grant 2019, and NAD+ IV tolerability studies. - [Botox vs Dysport: What's the Difference?](https://defianthealth.io/blog/botox-vs-dysport/): How the two botulinum toxin type A wrinkle relaxers compare. Both soften frown lines, forehead lines, and crow's feet by relaxing the underlying muscles. Dysport tends to have a slightly faster onset (2-3 days) and diffuses over a wider field (good for larger areas like the forehead); Botox stays more localized for precise placement. Dosing units are not interchangeable (about 20 units Botox vs 50 units Dysport for frown lines per the FDA labels), both last 3-4 months, and both are $11 per unit at Defiant in Lisle. Cites the FDA/DailyMed prescribing information for each. - [What Happens When You Stop Taking a GLP-1](https://defianthealth.io/blog/what-happens-when-you-stop-glp-1/): What the withdrawal trials (STEP 1 extension, STEP 4, SURMOUNT-4) show about weight regain after stopping semaglutide or tirzepatide, why it happens, and how to plan tapering, muscle preservation, and a maintenance dose. - [Why Weight Won't Budge in Perimenopause (and How GLP-1s May Help)](https://defianthealth.io/blog/perimenopause-glp1-weight-loss/): How declining estrogen drives midlife weight gain (abdominal fat, insulin resistance, muscle loss) and how medically supervised GLP-1 protocols in Lisle may support fat loss while protecting muscle. - [What to Expect Your First Month on a GLP-1](https://defianthealth.io/blog/first-month-on-glp-1/): Week-by-week guide to starting semaglutide or tirzepatide, covering starter doses, appetite changes, side effects, early weight loss, and the first titration decision. - [Best Peptides for Weight Loss](https://defianthealth.io/blog/peptides-for-weight-loss/): Which peptides actually drive weight loss (GLP-1s), and which ones support body composition or recovery without causing fat loss. - [Infrared Sauna vs Traditional Sauna](https://defianthealth.io/blog/infrared-sauna-vs-traditional-sauna/): Comparison of mechanism, cardiovascular load, tolerance, and use case. - [BPC-157 vs SARMs](https://defianthealth.io/blog/bpc-157-vs-sarms/): What the science says, including current FDA Category 2 status and the July 2026 advisory committee review. - [Tirzepatide vs Semaglutide](https://defianthealth.io/blog/tirzepatide-vs-semaglutide/): Head-to-head comparison of mechanism, trial data, and side effects. - [Protect Muscle on a GLP-1](https://defianthealth.io/blog/protect-muscle-on-glp-1/): How to preserve lean mass during medically supervised weight loss. - [What Is Peptide Therapy](https://defianthealth.io/blog/what-is-peptide-therapy/): Plain-English guide to peptide therapy categories and mechanisms. - [What Is BPC-157](https://defianthealth.io/blog/what-is-bpc-157/): Research-honest overview of the peptide and its FDA status. - [What Is Hyperbaric Oxygen Therapy](https://defianthealth.io/blog/what-is-hyperbaric-oxygen-therapy/): Mechanism, FDA-cleared indications, and emerging research. - [HBOT for Athletic Recovery](https://defianthealth.io/blog/hbot-athletic-recovery/): Recovery applications for athletes. - [The Longevity Stack](https://defianthealth.io/blog/longevity-stack-hbot-contrast-iv-peptides/): HBOT, contrast therapy, IV, and peptide stacking. ## Practice information - Location: 5100 Lincoln Ave, Lisle, IL 60532 - Service area: Lisle, Naperville, Downers Grove, Wheaton, Bolingbrook, Lombard, and the western Chicago suburbs - Booking: https://defianthealth.myaestheticrecord.com/online-booking - Contact: britt@defianthealth.io - Sitemap: https://defianthealth.io/sitemap.xml ## Editorial standards - Medical claims are hedged ("may support", "research suggests") unless tied to specific peer-reviewed clinical trial data. - FDA approval status is disclosed for every prescription compound and peptide discussed. - Off-label use is explicitly identified. - References are cited inline using superscript numbers tied to a numbered list at the bottom of each article.